Sign in

CIK 0001130598 · Non-accelerated filer<br>Smaller reporting company

Traws Pharma, Inc.

Sign in to watch
Ticker
TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
267-759-3680
Business address
12 PENNS TRAIL, NEWTOWN, PA, 18940
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-07 Fruchtman Steven M President, Chief Executive Off Grant or award · Stock Option (right to purchase) +191,880 191,880
2022-02-07 Fruchtman Steven M President, Chief Executive Off Grant or award · Restricted Stock Units +63,960 63,960
2022-02-07 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Grant or award · Stock Option (right to purchase) +54,050 54,050
2022-02-07 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Grant or award · Restricted Stock Units +17,633 17,633
2022-02-07 Guerin Mark Patrick Chief Financial Officer Grant or award · Stock Option (right to purchase) +62,100 62,100
2022-02-07 Guerin Mark Patrick Chief Financial Officer Grant or award · Restricted Stock Units +20,700 20,700
2022-01-28 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Purchase +1,500 $1.67 $3K 24,514
2022-01-21 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Purchase +1,500 $2.02 $3K 23,014
2022-01-14 OLER ABRAHAM N. SVP CORP DEV & GEN COUNSEL Purchase +1,500 $2.20 $3K 21,514
2022-01-07 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Purchase +1,500 $2.39 $4K 20,014

Page 9 of 9 · 170 trades